Share Name Share Symbol Market Type Share ISIN Share Description
Calculus Vct LSE:CLC London Ordinary Share GB00B631ZQ22 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 23.00p 19.00p 27.00p 23.00p 23.00p 23.00p 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.1 -0.1 -1.5 - 1.09

Calculus Vct Share Discussion Threads

Showing 326 to 350 of 350 messages
Chat Pages: 14  13  12  11  10  9  8  7  6  5  4  3  Older
DateSubjectAuthorDiscuss
21/4/2011
12:40
Orange1, Are you still about? I'm long gone from here (thank gawd) but the periodic results still catch my eye occasionally. It seems to have a familiar ring to it ("reduced losses")! Hope you are well.
jeffian
12/10/2010
07:53
hoper,got a few yesterday noticed it quicly moving up the leaderboard. Fingers crossed!
fortune44
12/10/2010
07:37
A few trades gone through,one of them was mine
22hoper
12/10/2010
07:11
After yesterdays late rise in sp,looks like rns is due imo
fortune44
12/10/2010
06:33
The Hydra Management part of the company is generating good cash and with new contracts things are looking up for clc.
22hoper
11/10/2010
20:01
Renal (Kidney) worth billions. Just a piece on such a tiny M/cap is huge!
fortune44
11/10/2010
19:59
Big deal coming, hold tight!!
fortune44
11/10/2010
19:57
Description Clinical Computing Plc is a United Kingdom-based company. The Company is engaged in development, distribution and support of computer software for the healthcare and project management markets. The Company has two businesses: Clinical Computing, which is a supplier of clinical information systems for management of chronic kidney disease and its product consist of Clinicalvison V, PROTON and RENLStar, and Hydra Management, which provide programme and resource management software company and its products are Hydra Manager, Hydra Personal, Hydra Reporter and Hydra Alerts. It derives its revenue from approximately 85 healthcare organizations who license products such as, PROTON, di- PROTON, RENLStar and clinicalvision. As of December 31, 2009, the Company's subsidiaries include Clinical Computing, Inc., Clinical Computing UK Limited, Clinical Computing PTY Limited, and Hydra Management Limited. Its subsidiaries are engaged in software sales, support and development
countesspoo
11/10/2010
19:57
Description Clinical Computing Plc is a United Kingdom-based company. The Company is engaged in development, distribution and support of computer software for the healthcare and project management markets. The Company has two businesses: Clinical Computing, which is a supplier of clinical information systems for management of chronic kidney disease and its product consist of Clinicalvison V, PROTON and RENLStar, and Hydra Management, which provide programme and resource management software company and its products are Hydra Manager, Hydra Personal, Hydra Reporter and Hydra Alerts. It derives its revenue from approximately 85 healthcare organizations who license products such as, PROTON, di- PROTON, RENLStar and clinicalvision. As of December 31, 2009, the Company's subsidiaries include Clinical Computing, Inc., Clinical Computing UK Limited, Clinical Computing PTY Limited, and Hydra Management Limited. Its subsidiaries are engaged in software sales, support and development
countesspoo
11/10/2010
17:35
Only 60 million shares in issue.. Country of Incorporation and operations: Clinical Computing Plc is incorporated in England and Wales. It trades through operating subsidiaries, which are registered in England and Wales, Australia and the United States. These are also the main countries of operations. The Group derives the majority of its revenue from the US market. AIM Securities The Company currently has 110,883,694 ordinary shares of 1 penny each in issue. 38.7% of the above shares are considered by AIM rules not to be in public hands. There are no restrictions as to transfer. Significant Shareholdings Name of Holder Ordinary shares of 1p Number Percentage held Emanuel Mond 14,005,000 12.63 David Altschuler* 12,381,496 11.17 Howard Kitchner* 9,744,163 8.79 Garry Crystal 9,139,517 8.24 Peter Rackind 7,983,500 7.20 GAM UK Diversified Fund 8,120,153 7.32 Neil Mendoza 6,483,334 5.85 Mike Gordon 5,811,800 5.24 GAM UK Exempt Opportunities 3,894,079 3.51 William Sieghart 4,022,200 3.63 Johnny Levy 3,975,000 3.58 *In addition to the shareholdings shown above, 203,008 ordinary shares are registered in the name of South Quay Plaza Retirement Fund, in which Messrs Kitchner and Altschuler are beneficially intereste
countesspoo
11/10/2010
15:55
Maybe this from lasr rns Clinical business During the period under review we are pleased to report two firsts for the business: we have secured our first US clinicalvision V hosted contract with a hospital-based customer and have completed the implementation of the first French-Canadian version of clinicalvision. In addition we have secured two clinicalvision V contracts with NHS customers one of which is a new customer for the business. The business is now managing seven concurrent implementations for clinicalvision and we are anticipating one go-live per month for the remainder of the year. Following the establishment of reference sites in our key markets we are actively involved in several regional tenders spread across Australia, UK and the US which we believe will be decided in the second half of 2010. Additionally we are working to capitalise on the footprint we have developed in the Canadian market
countesspoo
11/10/2010
15:33
Wow ! This has been to £1.70p and still only 100 milllion shares !
countesspoo
11/10/2010
15:30
Something going on ? Got a few just in case.
countesspoo
18/5/2009
10:37
is there life in this old dog ?
the shuffle man
30/10/2007
16:19
powwow Worrying about why a share you don't own has gone from 50p to 3p... happy days. I have held from 170p and am definitely "at odds" as to why it went from 170 to 3p. Luckily I have never held any other share so it has been enabled me to concentrate on this one. LOL!
orange1
30/10/2007
14:32
I new to this and as such have started researching the stock with a view of potentially investing. I'm at odds at how it went from 50p to 3p , so if anyone can help me in the first instance (LionelH ? Could you please as you've held for 6 years) I would be appreciate it.. Just want to understand the history of the company and why it is where it is today. Monthly cash burn ? too.
powwow
30/10/2007
08:34
No, just the placing at 3p.
garykc
30/10/2007
08:28
Top of the leader board, is news expected here??
5dally
09/10/2007
10:12
I've been in this share for five or six years now since I saw a buy recommendation in Techinvest. In that time it has lost over 90% of its value (I can remember when it was nearly 50p per share). My exposure to it has been small so I held on. For the first time I am seriously considering topping-up and averaging down. Continued improving newsflow can only start to move the share price ahead for a revaluation soon. It appears to be sticking a bit like ULT where continuing positive newsflow, including large NHS interest, over a period of time has failed to be recognised by the market. Cancellation of official listing should be a large saving but may lose instittional investors. I presume it will be an AIM listing instead. Good luck all patient investors.
lionelh
07/10/2007
21:15
Hey Guys we may see some action for the days or weeks to come...i was just reading the FT and i happen to come across this http://www.ft.com/cms/s/0/89fba648-7399-11dc-abf0-0000779fd2ac.html if you could all copy nd paste that. They are introducing 12bn to up their software systems etc. And if this does go ahead we should see this little company shine again..well thats my punt.
tgod
25/9/2007
09:03
Hi O1, Still sticking it out, I see. I think the projection was for 'one a month' in our day, wasn't it? Good luck! 8-) Regards, Ian
jeffian
25/9/2007
08:24
Well blow me: I believe they are dancing i the streets of Ipswich as I type this: The company is showing firm progress: In March 06 the company announced that the number of new licence sales in the previous 6 months had been ...: 0. In September 06 the number of new licence sales was ...3. In April 07, it was ...1. And now in September 07, it is a massive................. 4! We're on our way, we're on our way, we're on our ..............!!!!!
orange1
12/9/2007
09:23
Getting hold of any quantity of stock is extremely difficult . If you do manage to get a decent quantity , sit tight and let the market makers bid you up for it don`t give it away at these silly prices
readbetweenthelines
12/9/2007
09:05
I would suggest getting in on the ground level here and holding this for the coming year with the new contracts due : "It said it looks forward to reporting continued progress in the year ahead as nine clinical vision implementations will go live in 2007 " LONDON (Thomson Financial) - Clinical Computing PLC said full-year pretax loss narrowed by 39.6 pct and revenues increased by 7.6 pct, attributable to the restructuring programme initiated in the second half of 2005, adding it looksforward to improved results in the year ahead. The company, which develops computer systems for the healthcare sector, posted pretax loss of 964,638 stg from last year's 1.54 mln stg, while revenues stood at 1.78 mln stg against 1.65 mln stg. It said it looks forward to reporting continued progress in the year ahead as nine clinical vision implementations will go live in 2007. It said its restructuring programme is well underway with a new office opened in Ipswich, providing a base to concentrate on expanding product portfolio and delivering against the product roadmap. Reasons to buy at current level We`re priced at dilution levels , the chairman holds over 10% at double the level of todays stock price .Over 50% held tightly by directors and the recent RNS:29/06/2007 LONDON (Thomson Financial) - Clinical Computing PLC said it expects growth in revenue for the first half compared with the same period last year despite a weak US dollar, adding that it remains confident about its prospects. At its AGM, the developer of computer systems for the healthcare sector said it has seen its US and Australian operations generating cash during the first half. The group added that it is now working to implement its eight active Clinical Vision flagship products, with a future revenue opportunity above 1 mln stg. All of this and only a £1 million market cap , the market makers have priced this one incorrect . Buy
readbetweenthelines
16/7/2007
14:58
I thought that was my 250k...
diku
Chat Pages: 14  13  12  11  10  9  8  7  6  5  4  3  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20161206 16:03:03